Purified human neural stem cell therapy (Microbot Medical)

纯化人神经干细胞疗法

Report date: 2022/07/19 16:22:54

Base Information

Drug NamePurified human neural stem cell therapy (Microbot Medical)

Drug Alias NameNeurodegenerative disorders stem cell therapyHuCNS-SC cellsAdult neural stem cell therapyHuCNS-SChCNS-SC

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy

Mechanisms of ActionMyelin proteins stimulantsStem cell replacementsNeurogenesis stimulants

TargetsMyelin proteins

Therapy Area/IndicationsSpinal InjuriesMacular DegenerationNeuronal Ceroid-Lipofuscinoses +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesSwitzerland

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMicrobot Medical

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesStemcells Inc

Active IndicationsN/A

Inactive IndicationsSpinal InjuriesMacular DegenerationNeuronal Ceroid-Lipofuscinoses +[6]

Other Information

ATC CodeN/A